tradingkey.logo
tradingkey.logo
Search

Aprea Therapeutics Inc

APRE
Add to Watchlist
0.632USD
+0.004+0.70%
Close 07-24 16:00ETQuotes delayed by 15 min
7.57MMarket Cap
LossP/E TTM

APRE Financials

See Aprea Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Aprea Therapeutics Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.22/-0.23
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
285.76K
-80.98%
EPS(YoY)
-1.93
18.07%
Analyst Rating
STRONG BUY
2026/07/26
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
65.88%-0.22
34.37%-0.32
26.78%-0.47
8.90%-0.53
1.98%-0.66
47.25%-0.49
25.75%-0.64
33.08%-0.58
50.17%-0.67
-0.34%-0.92
---0.86
---0.87
---1.34
---0.92
---83.33
----
----
----
----
----
Revenue
-100.00%0.00
-98.38%3.34K
-99.48%1.85K
-78.97%118.11K
-57.31%162.46K
1362.29%205.82K
11.00%354.62K
124.91%561.57K
--380.57K
--14.07K
--319.47K
--249.69K
----
----
----
----
----
----
----
----
Net Profit
16.39%-3.29M
15.17%-2.46M
21.44%-2.97M
6.66%-3.24M
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
Net Margin
----
-5132.02%-73587.95%
-14974.63%-160844.70%
-343.79%-2742.23%
-227.83%-2420.65%
94.25%-1406.49%
-6.37%-1066.99%
52.66%-617.92%
---738.39%
---24463.62%
---1003.08%
---1305.27%
----
----
----
----
----
----
----
----
Gross Margin
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
Revenue
-100.00%0.00
-98.38%3.34K
-99.48%1.85K
-78.97%118.11K
-57.31%162.46K
1362.29%205.82K
11.00%354.62K
124.91%561.57K
--380.57K
--14.07K
--319.47K
--249.69K
----
----
----
----
----
----
----
----
Operating profit
16.04%-3.43M
18.07%-2.64M
23.91%-3.12M
11.94%-3.39M
-29.71%-4.09M
12.21%-3.23M
-16.30%-4.10M
-5.35%-3.85M
31.86%-3.15M
-38.59%-3.67M
16.13%-3.52M
83.73%-3.65M
42.75%-4.62M
66.13%-2.65M
55.46%-4.20M
-124.51%-22.45M
20.75%-8.07M
44.96%-7.83M
22.92%-9.43M
30.96%-10.00M
Net Profit
16.39%-3.29M
15.17%-2.46M
21.44%-2.97M
6.66%-3.24M
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
Current assets
138.20%47.25M
-34.00%15.56M
-47.35%13.94M
-42.74%16.93M
-40.02%19.83M
4.68%23.58M
3.29%26.48M
3.22%29.56M
3.28%33.07M
-25.31%22.52M
-23.40%25.64M
-29.22%28.64M
-36.02%32.02M
-46.71%30.15M
-46.17%33.47M
-43.25%40.46M
-37.51%50.04M
-38.77%56.58M
-39.28%62.18M
-37.64%71.30M
Total current liabilities
57.59%5.30M
-17.75%2.76M
-26.26%2.68M
2.37%3.17M
13.36%3.36M
-23.36%3.36M
-12.73%3.64M
-21.68%3.09M
-29.86%2.97M
37.00%4.39M
4.20%4.17M
-48.59%3.95M
-37.09%4.23M
-56.25%3.20M
-55.77%4.00M
-27.49%7.68M
-40.08%6.72M
-52.28%7.32M
-33.91%9.04M
-26.97%10.60M
Total assets
135.45%47.61M
-33.55%15.93M
-46.75%14.32M
-42.23%17.31M
-39.09%20.22M
5.87%23.98M
4.38%26.89M
4.48%29.96M
3.68%33.20M
-24.89%22.65M
-23.36%25.77M
-29.50%28.68M
-36.39%32.02M
-46.93%30.16M
-46.19%33.62M
-43.14%40.68M
-37.39%50.34M
-38.77%56.82M
-39.24%62.48M
-37.68%71.55M
Total liabilities
57.59%5.30M
-17.75%2.76M
-26.26%2.68M
2.37%3.17M
13.36%3.36M
-23.36%3.36M
-12.73%3.64M
-21.68%3.09M
-29.86%2.97M
37.00%4.39M
4.20%4.17M
-48.59%3.95M
-37.36%4.23M
-56.25%3.20M
-55.92%4.00M
-27.49%7.68M
-40.01%6.75M
-52.52%7.32M
-34.33%9.07M
-27.90%10.60M
Total equity
150.97%42.32M
-36.13%13.17M
-49.95%11.64M
-47.37%14.14M
-44.23%16.86M
12.89%20.62M
7.67%23.26M
8.66%26.87M
8.79%30.23M
-32.24%18.26M
-27.08%21.60M
-25.06%24.73M
-36.24%27.79M
-45.55%26.95M
-44.54%29.62M
-45.86%33.00M
-36.96%43.59M
-36.03%49.51M
-40.00%53.42M
-39.12%60.95M
Net operating income
24.08%-2.76M
15.65%-2.96M
-28.48%-3.17M
14.03%-3.13M
7.74%-3.63M
6.12%-3.51M
-10.10%-2.47M
-13.20%-3.64M
-32.12%-3.94M
6.99%-3.74M
65.99%-2.24M
63.87%-3.22M
45.79%-2.98M
60.50%-4.02M
19.93%-6.59M
-14.84%-8.90M
52.31%-5.50M
22.88%-10.18M
27.93%-8.23M
19.57%-7.75M
Net investment
----
----
----
----
----
100.00%0.00
100.00%0.00
---7.50K
---7.98K
---7.15K
---85.94K
----
----
--0.00
--0.00
--0.00
--0.00
100.00%0.00
-100.00%0.00
-100.00%0.00
Net financing
61896.01%34.62M
2758.20%3.84M
31090.48%357.94K
1927.54%384.88K
-99.62%55.85K
--134.41K
---1.16K
---21.06K
186.18%14.71M
-100.00%0.00
-100.00%0.00
--0.00
--5.14M
-94.06%98.53K
572.01%584.45K
--0.00
--0.00
--1.66M
--86.97K
-100.00%0.00

FAQs

What is the total revenue of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its total revenue reached 285.76K, with a year-on-year change of 1.50M.

What are the current assets of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its current assets were 15.56M, with a year-on-year change of -34.00.

What are the total assets of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its total assets of Aprea Therapeutics Inc were 15.93M, with a year-on-year change of -33.55.

What are the total liabilities of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its total liabilities of Aprea Therapeutics Inc were 2.76M, with a year-on-year change of -17.75.

What is the total equity of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its total equity of Aprea Therapeutics Inc was 13.17M, with a year-on-year change of -36.13.

What is the net operating income of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its net operating income of Aprea Therapeutics Inc was -13.23M, with a year-on-year change of 7.58.

What is the net financing of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its net financing of Aprea Therapeutics Inc was 4.64M, with a year-on-year change of -68.69.

What is the Earnings Per Share (EPS) of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.93, with a year-on-year change of 18.07.

What is the net income of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its net income was -12.60M, with a year-on-year change of 2.77.

What is the net margin of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its net profit margin was -4409.16, with a year-on-year change of -411.25.

What is the Return on Equity (ROE) of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -79.37, with a year-on-year change of -11.05.

What is the Return on Assets (ROA) of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -63.14, with a year-on-year change of -13.59.

What is the operating profit of Aprea Therapeutics Inc?

According to Aprea Therapeutics Inc's FY2025 earnings report, its operating profit was -13.23M, with a year-on-year change of 7.58.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.